CC

Commodore Capital Portfolio holdings

AUM $1.5B
1-Year Est. Return 149.78%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+149.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$632M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$58.5M
2
+$54.9M
3
+$38.4M
4
TERN icon
Terns Pharmaceuticals
TERN
+$36.4M
5
LBRX
LB Pharmaceuticals
LBRX
+$23.8M

Top Sells

1
+$51.4M
2
+$37.6M
3
+$30.2M
4
VERA icon
Vera Therapeutics
VERA
+$18.8M
5
DFTX
Definium Therapeutics
DFTX
+$16.6M

Sector Composition

1 Healthcare 99.61%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1
DELISTED
Merus
MRUS
$332M 16.2%
3,525,000
NUVL icon
2
Nuvalent
NUVL
$7.7B
$121M 5.91%
1,400,000
+25,000
XENE icon
3
Xenon Pharmaceuticals
XENE
$4.82B
$108M 5.29%
2,700,000
-325,000
COGT icon
4
Cogent Biosciences
COGT
$5.73B
$104M 5.08%
7,250,000
+4,938,836
ELVN icon
5
Enliven Therapeutics
ELVN
$1.72B
$96.1M 4.69%
4,692,809
AGIO icon
6
Agios Pharmaceuticals
AGIO
$1.62B
$93.9M 4.58%
2,338,287
+13,287
ALKS icon
7
Alkermes
ALKS
$4.61B
$92.9M 4.54%
3,096,754
+646,754
SLNO icon
8
Soleno Therapeutics
SLNO
$1.9B
$91.3M 4.46%
1,350,000
+740,000
RLAY icon
9
Relay Therapeutics
RLAY
$1.89B
$88.7M 4.33%
17,000,000
+3,650,000
CLDX icon
10
Celldex Therapeutics
CLDX
$1.99B
$78.3M 3.82%
3,028,335
-421,665
CNTA
11
Centessa Pharmaceuticals
CNTA
$4.02B
$69.1M 3.37%
2,850,000
-448,289
VRDN icon
12
Viridian Therapeutics
VRDN
$2.9B
$69.1M 3.37%
3,200,000
-1,675,000
PTGX icon
13
Protagonist Therapeutics
PTGX
$6.09B
$68.1M 3.32%
1,025,000
-50,000
PHVS icon
14
Pharvaris
PHVS
$1.71B
$60.3M 2.95%
2,418,476
+507,043
CDTX
15
DELISTED
Cidara Therapeutics
CDTX
$56M 2.73%
585,000
-590,000
AMLX icon
16
Amylyx Pharmaceuticals
AMLX
$1.58B
$55.4M 2.7%
+4,075,478
TYRA icon
17
Tyra Biosciences
TYRA
$1.94B
$47.2M 2.31%
3,375,000
+275,000
TERN icon
18
Terns Pharmaceuticals
TERN
$4.81B
$42.8M 2.09%
+5,700,000
KYMR icon
19
Kymera Therapeutics
KYMR
$6.33B
$42.5M 2.07%
750,000
DFTX
20
Definium Therapeutics
DFTX
$1.79B
$38M 1.86%
3,225,000
-1,775,000
NRIX icon
21
Nurix Therapeutics
NRIX
$1.61B
$34.9M 1.71%
3,780,055
-168,598
ORKA
22
Oruka Therapeutics
ORKA
$1.55B
$33.7M 1.65%
1,753,054
+333,340
SYRE icon
23
Spyre Therapeutics
SYRE
$3.17B
$33.3M 1.63%
1,988,084
DRUG
24
Bright Minds Biosciences
DRUG
$707M
$30.3M 1.48%
500,000
ASMB icon
25
Assembly Biosciences
ASMB
$448M
$25.6M 1.25%
+1,000,000
1
2